Cargando…
Immunotherapy for Chronic Hepatitis B Virus Infection
While new therapies for chronic hepatitis C virus infection have delivered remarkable cure rates, curative therapies for chronic hepatitis B virus (HBV) infection remain a distant goal. Although current direct antiviral therapies are very efficient in controlling viral replication and limiting the p...
Autores principales: | Bertoletti, Antonio, Le Bert, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143456/ https://www.ncbi.nlm.nih.gov/pubmed/29316747 http://dx.doi.org/10.5009/gnl17233 |
Ejemplares similares
-
Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015) -
Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?
por: Bertoletti, Antonio, et al.
Publicado: (2013) -
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition
por: Dandri, Maura, et al.
Publicado: (2021) -
SARS-CoV-2-specific T cells in infection and vaccination
por: Bertoletti, Antonio, et al.
Publicado: (2021) -
Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
por: Kennedy, Patrick T. F., et al.
Publicado: (2017)